Immunotherapy in Stage III NSCLC: The Practice-Changing Results of the PACIFIC Trial Usher in a New Standard (BMIC-006) - 102204

Spotlight
Video

Immunotherapy in Stage III NSCLC: The Practice-Changing Results of the PACIFIC Trial Usher in a New Standard (BMIC-006)

BeaconMedIC has 63 videos Subscribe Here

Loading........
Description: Dr. Jack West reviews data from ESMO 2017 & the NEJM paper on the PACIFIC trial of durvalumab vs. placebo as consolidation after chemoradiation for patients with unresectable stage III NSCLC, focusing especially on why these results are practice-changing.
Shared By : BeaconMedIC
Posted on : 09/09/17
Added : 1 year ago
Category : Immunotherapy